Dinuclear platinum(II) complexes could offer a more targeted approach to treating prostate cancer Post author: Post published:December 16, 2024 Post category:uncategorized Prostate cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer among men. You Might Also Like AI model predicts Alzheimer’s progression with new insights into racial and sex-based disparities November 5, 2024 Non-invasive blood test shows 83% sensitivity in detecting colorectal cancer, offering hope for early diagnosis March 18, 2024 Radnet’s DeepHealth and HOPPR forge partnership to advance AI in healthcare September 9, 2024
AI model predicts Alzheimer’s progression with new insights into racial and sex-based disparities November 5, 2024
Non-invasive blood test shows 83% sensitivity in detecting colorectal cancer, offering hope for early diagnosis March 18, 2024